Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR7280 in Premenopausal Women With Endometriosis
CTR20201002Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SHR7280 in endometriosis, adenomyosis, sponsored by Hengrui Therapeutics. Started Jun 2020; status: completed.
02
Drugs
SHR7280
03
Conditions
endometriosisadenomyosis
Beyond the preview
Go deeper on CTR20201002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201002.